ライフサイエンスコーパス: drug monitoring

1 ersonalize and optimize therapy (therapeutic drug monitoring).

2 amer-based sensors can be used for real-time drug monitoring.

3 al diagnosis or for personalized therapeutic drug monitoring.

4 ts, in vivo tissue sampling, and therapeutic drug monitoring.

5 ering a tool for pharmacodynamic therapeutic drug monitoring.

6 ce use variables associated with therapeutic drug monitoring.

7 ith bipolar disorder received no therapeutic drug monitoring.

8 delivery, molecular imaging, and therapeutic drug monitoring.

9 Drug monitoring allows individualization of a patient's

10 ccurate multiple sclerosis disease-modifying drug monitoring and decision making in the routine clini

11 rategy that incorporates routine therapeutic drug monitoring and dose adjustment over current standar

12 inetic variability by the use of therapeutic drug monitoring and include measurement of the risks of

13 multiple applications in, e.g., therapeutic drug monitoring and toxicology.

14 ly suppressed, in settings where therapeutic drug monitoring and/or close viral load monitoring are f

15 ent antibiotic plan, (8) perform therapeutic drug monitoring, and (9) discontinue antibiotic therapy

16 porate rapid fungal diagnostics, therapeutic drug monitoring, and clinical intervention teams.

17 as an ideal probe for forensic application, drug monitoring, and point-of care-diagnosis.

18 tions in bioreactors, environmental sensing, drug monitoring, controlled drug delivery, early disease

19 dosing software supplemented by therapeutic drug monitoring data should be embedded into daily pract

20 Therapeutic drug monitoring did not reveal any clinically significan

21 oanalytical applications such as therapeutic drug monitoring, doping in sports, and pharmacological s

22 include when to start therapy and with what drugs, monitoring for response and toxic effects, specia

23 Therapeutic drug monitoring has been added to our ALL-11 protocol to

24 has the potential to complement therapeutic drug monitoring in achieving target blood concentrations

25 those evaluating the role of MMF therapeutic drug monitoring in cardiac transplant recipients will be

26 etermine whether dosing based on therapeutic drug monitoring increases rate of remission and whether

27 of fluconazole improves outcome, therapeutic drug monitoring is currently not recommended.

28 Therapeutic drug monitoring is seen as a valuable tool to improve pa

29 Therapeutic drug monitoring may be advantageous when the CNI or MMF

30 The present study suggests that piperacillin drug monitoring might be necessary in the sickest patien

31 Therapeutic drug monitoring of fluconazole can be a valuable tool to

32 achieved without CNI drugs, when therapeutic drug monitoring of sirolimus is employed.

33 The utility of therapeutic drug monitoring on rejection prophylaxis and treatment i

34 s are used for therapeutic immunosuppressive drug monitoring (pharmacokinetics, PK).

35 not decline after adoption of a prescription-drug monitoring program (0.27 percentage points; 95% con

36 ved from California's statewide prescription drug monitoring program (PDMP) and county-level socioeco

37 s or more frequently and review prescription drug monitoring program data, when available, for high-r

38 ring pill counts, and reviewing prescription drug monitoring program data, when available.

39 ing data from medical examiner, prescription drug monitoring program, and opiate treatment program re

40 e possible, states have created prescription drug monitoring programs to collect records of scheduled

41 riginal data set of laws (e.g., prescription-drug monitoring programs), we examined the annual preval

42 er resources, such as state-run prescription drug monitoring programs, are also available to many phy

43 2001, interventions designed in response to drug-monitoring programs worldwide resulted in a reducti

44 address the lack of a reliable point-of-care drug monitoring system in the market.

45 Therapeutic drug monitoring (TDM) aid therapeutic decision making in

46 litates using the DBS method for therapeutic drug monitoring (TDM) for improving the efficacy and saf

47 The importance of therapeutic drug monitoring (TDM) in this population is also explore

48 herapeutic dosage range to which therapeutic drug monitoring (TDM) is applied.

49 d, Tong et al have reported that therapeutic drug monitoring (TDM) of asparaginase (ASP) activity lev

50 Therapeutic drug monitoring (TDM) provides valuable guidance for dos

51 nalytical platforms that perform therapeutic drug monitoring (TDM) without relying on mAb specific re

52 Therapeutic drug monitoring (TDM), which involves measurement of dru

53 making it an ideal candidate for therapeutic drug monitoring (TDM).

54 nical chemistry laboratories for therapeutic drug monitoring (TDM).

55 copy as point-of-care method for therapeutic drug monitoring (TDM).

56 re, it is highly recommended for therapeutic drug monitoring to control the drug level.

57 rating solution used in standard therapeutic drug monitoring to detach the drug from the proteins tha

58 travenous busulfan combined with therapeutic drug monitoring to guide dosing improves outcomes after

59 viral susceptibility testing and therapeutic drug monitoring to identify the optimal treatment for ea